Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-18T15:13:52.178Z Has data issue: false hasContentIssue false
  • English
  • Français

The Cost of Antibiotic Resistance: Effect of Resistance Among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on Length of Hospital Stay

Published online by Cambridge University Press:  02 January 2015

The Brooklyn Antibiotic Resistance Task Force
Get access Rights & Permissions [Opens in a new window]

Abstract

To assess the effect of antimicrobial resistance on length of hospital stay, a case–control study compared infections due to four nosocomial pathogens. Significantly increased lengths of stay were associated with infections due to methicillin-resistant Staphylococcus aureus, extended-spectrum β-lactamase–producing Klebsiella pneumoniae, and carbapenem-resistant Acinetobacter baumannii or Pseudomonas aeruginosa. Infections with resistant pathogens are associated with prolonged hospitalization.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 2 , February 2002 , pp. 106 - 108
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Altman, LK. Experts see need to control antibiotics and hospital infections. New York Times March 12, 1998; section A, p 12.Google Scholar
2.Saurina, G, Quale, JM, Manikal, VM, Oydna, E, Landman, D. Antimicrobial-resistant Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000;45:895–898.Google Scholar
3.Manikal, VM, Landman, D, Saurina, G, Oydna, E, Lal, H, Quale, J. Endemic carbapenem-resistant Acinetobacter-sp. in Brooklyn, NY: citywide prevalence, inter-institutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101–106.CrossRefGoogle Scholar
4.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
5.Wakefield, DS, Helms, CM, Mori, M, Pfaller, M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185–192.CrossRefGoogle ScholarPubMed
6.Saravolatz, LD, Markowitz, N, Arking, L, Pohlod, D, Fisher, E. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982;96:11–16.Google Scholar
7.Boyce, JM, Landry, M, Deetz, TR, DuPont, HL. Epidemiologic studies of an outbreak of methicillin-resistant Staphylococcus aureus infections. Infect Control 1981;2:110–116.CrossRefGoogle ScholarPubMed
8.Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and methi-cillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408–411.CrossRefGoogle ScholarPubMed
9.Lautenbauch, E, Patel, JB, Bilker, WB, Edelstein, PH, Fishman, NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162–1171.CrossRefGoogle Scholar
10.Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infection. Med Care 1987;25:481–488.Google Scholar